Chronic Kidney Disease
📧 Sign up to get email alerts when something new happens for Chronic Kidney Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-12-01Clinical Trial Update: A Trial of Bardoxolone Methyl in Patients With CKD at Risk of Rapid Progression (MERLIN) [Phase 2]
This document reports the completion of the MERLIN Phase 2 trial evaluating bardoxolone methyl in patients with chronic kidney disease at ri…
-
CLINICAL_TRIALS withdrawal · 2022-11-23Clinical Trial Update: A Research Study to Show Aprocitentan is Efficacious and Safe to Treat Patients With Uncontrolled Blood Pressure and Chronic Kidney Disease. [Phase 3]
Phase 3 trial of aprocitentan for uncontrolled blood pressure in chronic kidney disease was withdrawn.
-
CLINICAL_TRIALS trial_result · 2022-11-03Clinical Trial Update: Safe Use of Heparin Sodium in Patients With Chronic Renal Failure. [Phase 2, Phase 3]
Clinical trial update on the safe use of heparin sodium in patients with chronic renal failure; study status is suspended for Phase 2 and Ph…
-
CLINICAL_TRIALS trial_result · 2022-10-28Clinical Trial Update: Effect of Sotagliflozin on Cardiovascular and Renal Events in Participants With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk [Phase 3]
Phase 3 trial evaluating sotagliflozin in type 2 diabetes with moderate renal impairment at cardiovascular risk; study terminated with poste…
-
FDA approval · 2022-10-24FDA Approved: METOLAZONE — Original Application (Ingenus Pharmaceuticals LLC)
FDA approves Metolazone via Original Application for a generic version by Ingenus Pharmaceuticals LLC. The approval supports its use for ede…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA label_change · 2022-10-20FDA Approved: ZEMPLAR — Supplemental Application (AbbVie Inc.)
FDA approved a supplemental application for ZEMPLAR (paricalcitol) filed by AbbVie, resulting in changes to its labeling.
-
CLINICAL_TRIALS trial_result · 2022-10-14Clinical Trial Update: Evaluation of Effect of TRC101 on Progression of Chronic Kidney Disease in Subjects With Metabolic Acidosis [Phase 3]
Phase 3 trial evaluating TRC101 for slowing progression of chronic kidney disease in patients with metabolic acidosis was terminated.
-
CLINICAL_TRIALS trial_result · 2022-09-26Clinical Trial Update: Pharmacodynamic & Safety of Patiromer in Children & Adolescents (2-<18 Yrs) With Chronic Kidney Disease and Hyperkalemia [Phase 2]
Phase 2 trial evaluating pharmacodynamics and safety of patiromer in children and adolescents with chronic kidney disease and hyperkalemia; …
-
CLINICAL_TRIALS trial_result · 2022-09-14Clinical Trial Update: Evaluation of Protective Effect of Activated Charcoal and Probiotic Against Progression of Chronic Kidney Disease [Phase 2, Phase 3]
Phase 2/Phase 3 trial evaluating protective effects of activated charcoal and a probiotic on progression of chronic kidney disease associate…
-
CLINICAL_TRIALS trial_result · 2022-09-06Clinical Trial Update: Effect of Oral Magnesium on Vascular Calcification in Chronic Kidney Disease [Phase 2]
Phase 2 trial investigating whether oral magnesium can affect vascular calcification in chronic kidney disease.
-
FDA approval · 2022-08-31FDA Approved: FUROSEMIDE — Supplemental Application (Hospira, Inc.)
FDA approved a supplemental application for furosemide from Hospira, Inc.
-
CLINICAL_TRIALS trial_result · 2022-08-30Clinical Trial Update: Sodium Bicarbonate Supplementation in Chronic Kidney Disease Evaluation of Dose Response, Safety and Beneficial Effects [Phase 2, Phase 3]
A Phase 2/3 trial evaluating sodium bicarbonate supplementation in chronic kidney disease for dose-response, safety, and beneficial effects …
-
CLINICAL_TRIALS trial_result · 2022-08-26Clinical Trial Update: Phosphate Lowering in CKD Trial [Phase 4]
A Phase 4 trial examining phosphate lowering in chronic kidney disease with cardiovascular disease has completed and results were posted in …
-
CLINICAL_TRIALS trial_result · 2022-08-24Clinical Trial Update: The Impact of Urate-lowering Therapy on Kidney Function (IMPULsKF) [Phase 4]
A phase 4 clinical trial assessing the impact of urate-lowering therapy on kidney function in patients with gout and chronic kidney disease …
-
CLINICAL_TRIALS trial_result · 2022-08-23Clinical Trial Update: Human Umbilical Cord Mesenchymal Stem Cell(UC-MSC)Delayed Renal Chronic Kidney Disease(CKD3、4 ) [Phase 1, Phase 2]
Clinical trial update for human umbilical cord mesenchymal stem cells in chronic kidney disease (stages 3-4) spanning Phase 1 and Phase 2.
-
CLINICAL_TRIALS trial_result · 2022-08-16Clinical Trial Update: Acute Effects of Intravenous Iron on Oxidative Stress and Endothelial Dysfunction in Non-dialysis CKD [Phase 4]
Phase 4 clinical trial assessing the acute effects of intravenous iron on oxidative stress and endothelial dysfunction in non-dialysis chron…
-
CLINICAL_TRIALS trial_result · 2022-08-11Clinical Trial Update: Does Correction of 25 OH-VITAmin D With Cholecalciferol Supplementation Increase Muscle Strength in hemoDIALysis Patients? [Phase 3]
A Phase 3 clinical trial evaluating whether correcting 25-hydroxy vitamin D with cholecalciferol supplementation improves muscle strength in…
-
CLINICAL_TRIALS trial_result · 2022-08-09Clinical Trial Update: Does Intravenous Iron Therapy Decrease Serum Phosphorous Levels?
A completed clinical trial evaluating whether intravenous iron therapy lowers serum phosphorus levels in chronic renal failure, with results…
-
FDA approval · 2022-08-04FDA Approved: BUMETANIDE — Original Application (Novadoz Pharmaceuticals LLC)
FDA approves the original ANDA for bumetanide (generic) by Novadoz Pharmaceuticals LLC for use in edema associated with congestive heart fai…
-
CLINICAL_TRIALS trial_result · 2022-08-03Clinical Trial Update: Symbiotics and Systemic Inflammation in Chronic Kidney Disease [Phase 2]
Phase 2 clinical trial exploring symbiotics effects on systemic inflammation in chronic kidney disease with Type 2 diabetes.
-
CLINICAL_TRIALS trial_result · 2022-08-01Clinical Trial Update: Project to Improve Communication About Serious Illness--Hospital Study: Pragmatic Trial (Trial 1) [NA]
Completed pragmatic trial evaluating methods to improve communication about serious illness; results have been posted (2022-08-01).
-
CLINICAL_TRIALS withdrawal · 2022-07-28Clinical Trial Update: Evolocumab In Advanced Chronic Kidney Disease Trial [Phase 4]
A Phase 4 trial of evolocumab in advanced chronic kidney disease has been withdrawn.
-
FDA approval · 2022-07-20FDA Approved: LANTHANUM CARBONATE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' supplemental application for Lanthanum carbonate.
-
CLINICAL_TRIALS trial_result · 2022-07-14Clinical Trial Update: Trial of Oral Glutamine on Mitochondrial Function in CKD [Phase 2]
Phase 2 trial assessing oral glutamine effects on mitochondrial function in CKD; study completed with results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-07-14Clinical Trial Update: Activity Trackers for Improving BP [NA]
Completed clinical trial investigating activity trackers to improve blood pressure in hypertension and cardiovascular risk contexts; results…